Midas Management’s Pfizer PFE Stock Holding History

Midas Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-36,890	Closed	-$1.53M	–	127
2018 Q4	$1.53M	Hold	36,890	–	–	0.73%	73
2018 Q3	$1.54M	Buy	+36,890	New	+$1.42M	0.69%	71
2016 Q1	–	Sell	-42,160	Closed	-$1.29M	–	176
2015 Q4	$1.29M	Buy	42,160 +2,188	+5%	+$68.8K	0.77%	63
2015 Q3	$1.19M	Hold	39,972	–	–	0.77%	70
2015 Q2	$1.27M	Hold	39,972	–	–	0.68%	79
2015 Q1	$1.32M	Hold	39,972	–	–	0.66%	87
2014 Q4	$1.18M	Hold	39,972	–	–	0.62%	89
2014 Q3	$1.12M	Hold	39,972	–	–	0.62%	82
2014 Q2	$1.13M	Hold	39,972	–	–	0.73%	74
2014 Q1	$1.22M	Hold	39,972	–	–	0.57%	95
2013 Q4	$1.16M	Hold	39,972	–	–	0.55%	97
2013 Q3	$1.09M	Hold	39,972	–	–	0.7%	67
2013 Q2	$1.06M	Buy	+39,972	New	+$1.1M	0.71%	64

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Midas Management's PFE Position: Q1 2019 in Review

Midas Management sold out of Pfizer (PFE) in Q1 2019, closing a stake of 36,890 shares — an estimated $1.53M sold.

Midas Management first reported a position in PFE in Q2 2013 and held it in 13 quarters. The position peaked at $1.54M in Q3 2018. 2,392 funds tracked by Wall St. Rank hold PFE as of Q1 2019.

Midas Management reported no remaining Pfizer position as of Q1 2019 after selling out during the quarter.
Midas Management sold 36,890 Pfizer shares in Q1 2019, an estimated $1.53M.
Midas Management first reported a position in Pfizer in Q2 2013 and held it in 13 quarters.
Midas Management's Pfizer position peaked at $1.54M in Q3 2018.
2,392 funds tracked by Wall St. Rank held Pfizer as of Q1 2019.

Based on Midas Management's 13F filing for Q1 2019, filed 25 Apr 2019.